Loading clinical trials...

Host Immune Response to Clostridium Difficile Infection (ICD) | Clinical Trials | Clareo Health

COMPLETEDNANCT02440438

Host Immune Response to Clostridium Difficile Infection (ICD)

Clostridium difficile is responsible for up to 25% of reported antibiotic associated diarrhea cases and virtually all cases of pseudomembranous colitis (PMC). The clinical spectrum of C. difficile inf...

Lead sponsor: Hospices Civils de Lyon•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Start Free Trial

Trial snapshot

StatusCOMPLETED

PhaseNA

Enrollment56

Start dateJan 2014

Last updatedDec 19, 2025

Condition

Diarrhea Due to Clostridium Difficile

Locations shown

Service d'Hygiène, Epidémiologie et Prévention - Hôpital Edouard Herriot

Lyon

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: December 19, 2025Data synced to Clareo: May 10, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions